Panel Discussion: Does Cancer have a Future? What’s Next? Where Will We Be in 2025?


Apella by Alexandria April 16, 2020 2:15 pm - 3:15 pm

Bookmark and Share

Lynne Zydowsky, PhD

In cell and gene therapy, the patient is both the process and the product. What are the challenges faced by companies in building new drug development teams and processes to meet the requirements of cell and gene therapy? How has your company adjusted to cell and gene product approval requirements, reimbursement, access and manufacturing challenges?